Mechanisms and diagnostic evaluation of persistent or recurrent angina following percutaneous coronary revascularization
- PMID: 30608528
- DOI: 10.1093/eurheartj/ehy857
Mechanisms and diagnostic evaluation of persistent or recurrent angina following percutaneous coronary revascularization
Abstract
Persistence or recurrence of angina after a percutaneous coronary intervention (PCI) may affect about 20-40% of patients during short-medium-term follow-up. This appears to be true even when PCI is 'optimized' using physiology-guided approaches and drug-eluting stents. Importantly, persistent or recurrent angina post-PCI is associated with a significant economic burden. Healthcare costs may be almost two-fold higher among patients with persistent or recurrent angina post-PCI vs. those who become symptom-free. However, practice guideline recommendations regarding the management of patients with angina post-PCI are unclear. Gaps in evidence into the mechanisms of post-PCI angina are relevant, and more research seems warranted. The purpose of this document is to review potential mechanisms for the persistence or recurrence of angina post-PCI, propose a practical diagnostic algorithm, and summarize current knowledge gaps.
Keywords: Coronary microvascular dysfunction; Coronary spasm; Coronary stenosis; Percutaneous coronary intervention; Stable angina.
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.
Similar articles
-
Angina after percutaneous coronary intervention: The need for precision medicine.Int J Cardiol. 2017 Dec 1;248:14-19. doi: 10.1016/j.ijcard.2017.07.105. Epub 2017 Aug 12. Int J Cardiol. 2017. PMID: 28807510 Review.
-
Persistent or Recurrent Angina Following Percutaneous Coronary Revascularization.Curr Cardiol Rep. 2022 Dec;24(12):1837-1848. doi: 10.1007/s11886-022-01820-3. Epub 2022 Oct 26. Curr Cardiol Rep. 2022. PMID: 36287295 Review.
-
Role of endothelial dysfunction in determining angina after percutaneous coronary intervention: Learning from pathophysiology to optimize treatment.Prog Cardiovasc Dis. 2020 May-Jun;63(3):233-242. doi: 10.1016/j.pcad.2020.02.009. Epub 2020 Feb 13. Prog Cardiovasc Dis. 2020. PMID: 32061633 Review.
-
Angina and associated healthcare costs following percutaneous coronary intervention: A real-world analysis from a multi-payer database.Catheter Cardiovasc Interv. 2016 Dec;88(7):1017-1024. doi: 10.1002/ccd.26365. Epub 2016 Jan 17. Catheter Cardiovasc Interv. 2016. PMID: 26774951
-
Endothelial dysfunction as predictor of angina recurrence after successful percutaneous coronary intervention using second generation drug eluting stents.Eur J Prev Cardiol. 2018 Sep;25(13):1360-1370. doi: 10.1177/2047487318777435. Epub 2018 May 22. Eur J Prev Cardiol. 2018. PMID: 29785885
Cited by
-
Angina due to coronary artery spasm after a percutaneous coronary intervention.Eur Heart J Suppl. 2019 Nov;21(Suppl G):G30-G31. doi: 10.1093/eurheartj/suz200. Epub 2019 Nov 12. Eur Heart J Suppl. 2019. PMID: 31736671 Free PMC article. No abstract available.
-
Impact of Antiplatelet Therapy on 5-Year Outcomes After Fractional Flow Reserve-Guided Deferral of Revascularization in Nonsignificant Obstructive Coronary Artery Disease.Circ Rep. 2024 Jul 20;6(8):313-321. doi: 10.1253/circrep.CR-24-0069. eCollection 2024 Aug 9. Circ Rep. 2024. PMID: 39132333 Free PMC article.
-
Pathophysiology and Diagnosis of Coronary Functional Abnormalities.Eur Cardiol. 2021 Sep 3;16:e30. doi: 10.15420/ecr.2021.23. eCollection 2021 Feb. Eur Cardiol. 2021. PMID: 34603510 Free PMC article. Review.
-
Beyond the Obstructive Paradigm: Unveiling the Complex Landscape of Nonobstructive Coronary Artery Disease.J Clin Med. 2024 Aug 7;13(16):4613. doi: 10.3390/jcm13164613. J Clin Med. 2024. PMID: 39200755 Free PMC article. Review.
-
Coronary Artery Bypass Grafting in Women 50 Years or Younger.J Am Heart Assoc. 2019 Sep 17;8(18):e013211. doi: 10.1161/JAHA.119.013211. Epub 2019 Sep 14. J Am Heart Assoc. 2019. PMID: 31522591 Free PMC article.